In Brief:
Precis: The Open Payments Program (OPP), established in 2013, mandates that medical device and pharmaceutical manufacturers submit record of any financial incentive given to physicians to the Centers for Medicare and Medicaid Services. This study aims to characterize these payments to transplant surgeons over the first six years of OPP data.
Go to Full Text of this Article